Sign in

CIK 0000863894

  • Non-accelerated filer
  • Smaller reporting company
Ticker
VERU
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
WI
Entity type
Operating
EIN
391144397
Phone
+1 312-595-9123
Business address
2916 N. MIAMI AVENUE, SUITE 1000, MIAMI, FL, 33127
Former names
FEMALE HEALTH CO
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market buy Director bought 5,000 shares at $2.76 ($13,800)
  3. 4 Open-market buy CAO and CFO bought 5,000 shares at $2.65 ($13,233)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Open-market buy Director bought 1,000 shares at $4.47 ($4,470)
  6. 4 Open-market buy Director bought 1,000 shares at $4.51 ($4,510)
  7. 4 Open-market buy Director bought 5,000 shares at $4.27 ($21,350)
  8. 4 Open-market buy Director bought 5,000 shares at $2.80 ($14,000)
  9. 4 Open-market sale President and CEO sold 25,000 shares at an average $2.21 ($55,340)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Open-market sale President and CEO sold 25,000 shares at an average $1.99 ($49,766)
  18. 4 Open-market sale President and CEO sold 15,836 shares at an average $2.06 ($32,593)
  19. 4 Open-market sale President and CEO sold 14,164 shares at an average $2.11 ($29,954)
  20. 4 Open-market sale President and CEO sold 30,000 shares at an average $1.93 ($57,919)

Page 6 of 30 · 594 filings